These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 19887275)

  • 41. Magnesium-induced recurarisation after reversal of rocuronium-induced neuromuscular block with sugammadex. Findings vs. speculation.
    Carron M; Ori C
    Acta Anaesthesiol Scand; 2015 Aug; 59(7):946-7. PubMed ID: 25962433
    [No Abstract]   [Full Text] [Related]  

  • 42. Where's the Fire?
    Wax D
    Anesth Analg; 2007 Sep; 105(3):877-8; author reply 878. PubMed ID: 17717256
    [No Abstract]   [Full Text] [Related]  

  • 43. [Sugammadex and profound rocuronium neuromuscular blockade induced by magnesium sulphate].
    Grandjean B; Guerci P; F Vial ; Raft J; Fuchs-Buder T; Bouaziz H
    Ann Fr Anesth Reanim; 2013 May; 32(5):378-9. PubMed ID: 23664923
    [No Abstract]   [Full Text] [Related]  

  • 44. Use of sugammadex for reversal of neuromuscular blockade in 2 patients requiring intraoperative neurophysiological monitoring.
    Reid S; Shields MO; Luney SR
    J Neurosurg Anesthesiol; 2011 Jan; 23(1):56-7. PubMed ID: 21248496
    [No Abstract]   [Full Text] [Related]  

  • 45. [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].
    Sparr HJ; Booij LH; Fuchs-Buder T
    Anaesthesist; 2009 Jan; 58(1):66-80. PubMed ID: 19082568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sugammadex: another milestone in clinical neuromuscular pharmacology.
    Naguib M
    Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Effective reversal of muscle relaxation by rocuronium using sugammadex in a patient with myasthenia gravis undergoing laparoscopic cholecystectomy].
    Komasawa N; Noma H; Sugi T; Sukenaga N; Kakiuchi H
    Masui; 2011 Apr; 60(4):476-9. PubMed ID: 21520600
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of cyclodextrin (sugammadex) for reversal of intense neuromuscular block of rocuronium and vecuronium, experimental and clinical studies.
    Alkenany HM
    J Egypt Soc Parasitol; 2013 Dec; 43(3):705-14. PubMed ID: 24640870
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Experience on the use of sugammadex in a French university hospital].
    Beny K; Mirabaud AF; Piriou V; Aulagner G; Armoiry X
    Ann Fr Anesth Reanim; 2012 Jun; 31(6):568-9. PubMed ID: 22543096
    [No Abstract]   [Full Text] [Related]  

  • 50. New drug sugammadex: a selective relaxant binding agent.
    Welliver M
    AANA J; 2006 Oct; 74(5):357-63. PubMed ID: 17048555
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Bisschops MM; Holleman C; Huitink JM
    Anaesthesia; 2010 Sep; 65(9):936-41. PubMed ID: 21198485
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
    Sacan O; White PF; Tufanogullari B; Klein K
    Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Feasibility of a 'reversed' isolated forearm technique by regional antagonization of rocuronium-induced neuromuscular block: a pilot study.
    Hamp T; Mairweck M; Schiefer J; Krammel M; Pablik E; Wolzt M; Plöchl W
    Br J Anaesth; 2016 Jun; 116(6):797-803. PubMed ID: 26934944
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Magnesium sulphate effects on sugammadex reversal time - a reply.
    Germano Filho PA
    Anaesthesia; 2015 Dec; 70(12):1457-8. PubMed ID: 26558864
    [No Abstract]   [Full Text] [Related]  

  • 55. A randomized simultaneous comparison of acceleromyography with a peripheral nerve stimulator for assessing reversal of rocuronium-induced neuromuscular blockade with sugammadex.
    Drobnik L; Sparr HJ; Thörn SE; Khuenl-Brady KS; Rietbergen H; Prins ME; Ullman J
    Eur J Anaesthesiol; 2010 Oct; 27(10):866-73. PubMed ID: 20523215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Can sugammadex save a patient in a simulated 'cannot intubate, cannot ventilate' situation?
    Mercer SJ; Moneypenny MJ
    Anaesthesia; 2011 Mar; 66(3):223-4. PubMed ID: 21320093
    [No Abstract]   [Full Text] [Related]  

  • 57. Sugammadex approved to reverse NMBA effects.
    Thompson CA
    Am J Health Syst Pharm; 2016 Feb; 73(3):100. PubMed ID: 26796899
    [No Abstract]   [Full Text] [Related]  

  • 58. Sugammadex: a revolutionary approach to neuromuscular antagonism.
    Kopman AF
    Anesthesiology; 2006 Apr; 104(4):631-3. PubMed ID: 16571954
    [No Abstract]   [Full Text] [Related]  

  • 59. [Sugammadex: the last shot for anaphylactic shock due to rocuronium?].
    Abad Gurumeta A; Gutiérrez García R
    Rev Esp Anestesiol Reanim; 2012 Apr; 59(4):177-9. PubMed ID: 22575774
    [No Abstract]   [Full Text] [Related]  

  • 60. Early reversal of profound rocuronium-induced neuromuscular blockade by sugammadex in a randomized multicenter study: efficacy, safety, and pharmacokinetics.
    Sparr HJ; Vermeyen KM; Beaufort AM; Rietbergen H; Proost JH; Saldien V; Velik-Salchner C; Wierda JM
    Anesthesiology; 2007 May; 106(5):935-43. PubMed ID: 17457124
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.